Vana Kolovou

1.0k total citations
49 papers, 673 citations indexed

About

Vana Kolovou is a scholar working on Surgery, Endocrinology, Diabetes and Metabolism and Molecular Biology. According to data from OpenAlex, Vana Kolovou has authored 49 papers receiving a total of 673 indexed citations (citations by other indexed papers that have themselves been cited), including 26 papers in Surgery, 17 papers in Endocrinology, Diabetes and Metabolism and 12 papers in Molecular Biology. Recurrent topics in Vana Kolovou's work include Lipoproteins and Cardiovascular Health (21 papers), Diabetes, Cardiovascular Risks, and Lipoproteins (10 papers) and Pharmacogenetics and Drug Metabolism (8 papers). Vana Kolovou is often cited by papers focused on Lipoproteins and Cardiovascular Health (21 papers), Diabetes, Cardiovascular Risks, and Lipoproteins (10 papers) and Pharmacogenetics and Drug Metabolism (8 papers). Vana Kolovou collaborates with scholars based in Greece, United Kingdom and Netherlands. Vana Kolovou's co-authors include Genovefa Kolovou, Sophie Mavrogeni, Niki Katsiki, Georgia Ragia, Vangelis G. Manolopoulos, Anna Tavridou, Ioannis Vasiliadis, Constantinos Mihas, Efstratios Maltezos and Peggy Kostakou and has published in prestigious journals such as New England Journal of Medicine, European Heart Journal and BioMed Research International.

In The Last Decade

Vana Kolovou

48 papers receiving 653 citations

Peers

Countries citing papers authored by Vana Kolovou

Since Specialization

Citations

This map shows the geographic impact of Vana Kolovou's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Vana Kolovou with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Vana Kolovou more than expected).

Fields of papers citing papers by Vana Kolovou

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Vana Kolovou. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Vana Kolovou. The network helps show where Vana Kolovou may publish in the future.

Co-authorship network of co-authors of Vana Kolovou

This figure shows the co-authorship network connecting the top 25 collaborators of Vana Kolovou. A scholar is included among the top collaborators of Vana Kolovou based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Vana Kolovou. Vana Kolovou is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Non-traumatic and non-drug-induced rhabdomyolysis 2019 ·Archives of Medical Science - Atherosclerotic Diseases ·Genovefa Kolovou, (unknown), Helen Bilianou, Vana Kolovou, Niki Katsiki, Sophie Mavrogeni	7
2	Rationale and design of the Greek registry for familial hypercholesterolemia (GRegistry-FH) of the hellenic college of treatment of atherosclerosis (HCTA) 2019 ·Hellenic Journal of Cardiology ·Genovefa Kolovou, (unknown), Stamatis S. Makrygiannis, (unknown), (unknown), Petros Kalogeropoulos, (unknown), (unknown), (unknown), (unknown), Despina Perrea, Vana Kolovou, Helen Bilianou	1
3	Biomarkers and Gene Polymorphisms in Members of Long- and Short-lived Families: A Longevity Study 2018 ·The Open Cardiovascular Medicine Journal ·Vana Kolovou, (unknown), Athanasia Papazafiropoulou, Niki Katsiki, Elisabeth Fragopoulou, Ioannis Vasiliadis, (unknown), Leonidas H. Duntas, Smaragdi Antonopoulou, Genovefa Kolovou	4
4	Five gene variants in nonagenarians, centenarians and average individuals 2017 ·Archives of Medical Science ·Vana Kolovou, Helen Bilianou, (unknown), Petros Kalogeropoulos, Constantinos Mihas, (unknown), Dennis V. Cokkinos, Maria Boutsikou, (unknown), Sophie Mavrogeni, Niki Katsiki, Genovefa Kolovou	7
5	Statins Treatment under the Umbrella of Pharmacogenetics 2015 ·ICUS and Nursing Web Journal ·Vana Kolovou, (unknown)	1
6	Angiotensinogen (AGT) M235T, AGT T174M and Angiotensin-1- Converting Enzyme (ACE) I/D Gene Polymorphisms in Essential Hypertension: Effects on Ramipril Efficacy 2015 ·The Open Cardiovascular Medicine Journal ·Vana Kolovou, (unknown), Constantinos Mihas, (unknown), Niki Katsiki, (unknown), Filippos Triposkiadis, (unknown), Sophie Mavrogeni, Genovefa Kolovou	22
7	Study of common variants of the apolipoprotein E and lipoprotein lipase genes in patients with coronary heart disease and variable body mass index 2015 ·HORMONES ·Genovefa Kolovou, Vana Kolovou, Demosthenes B. Panagiotakos, Ioannis Vasiliadis, (unknown), Peggy Kostakou, (unknown), Sophie Mavrogeni	2
8	Pharmacogenetics and Statin Treatment: Reality or Theory? 2015 ·Current Vascular Pharmacology ·(unknown), Vana Kolovou, Δέσποινα Περρέα, Genovefa Kolovou	5
9	Lipidomics in vascular health: current perspectives 2015 ·Vascular Health and Risk Management ·Genovefa Kolovou, Vana Kolovou, Sophie Mavrogeni	24
10	No effect of CYP3A4 intron 6 C>T polymorphism ( CYP3A4 22) on lipid-lowering response to statins in Greek patients with primary hypercholesterolemia 2014 ·Drug Metabolism and Personalized Therapy* ·Georgia Ragia, Vana Kolovou, Anna Tavridou, Laure Elens, Alexandros D. Tselepis, Moses Elisaf, Ron H. N. van Schaik, Genovefa Kolovou, Vangelis G. Manolopoulos	18
11	Impact of 3 Common ABCA1 Gene Polymorphisms on Optimal vs Non-Optimal Lipid Profile in Greek Young Nurses 2014 ·The Open Cardiovascular Medicine Journal ·(unknown), Vana Kolovou, Niki Katsiki, Maria Boutsikou, Αναστασία Κοτανίδου, Stylianos E. Orfanos, Gerasimos Filippatos, (unknown), (unknown), Sophie Mavrogeni, Genovefa Kolovou	13
12	Body Mass Index, Lipid Metabolism and Estrogens: Their Impact on Coronary Heart Disease 2014 ·Current Medicinal Chemistry ·Genovefa Kolovou, Vana Kolovou, Peggy Kostakou, Sophie Mavrogeni	19
13	Impact of CYP3A5 Gene Polymorphism on Efficacy of Simvastatin 2014 ·The Open Cardiovascular Medicine Journal ·Genovefa Kolovou, Georgia Ragia, Vana Kolovou, Constantinos Mihas, Niki Katsiki, Ioannis Vasiliadis, Sophie Mavrogeni, (unknown), Anna Tavridou, Vangelis G. Manolopoulos	8
14	Lack of Association of the P450 Oxidoreductase 28 Single Nucleotide Polymorphism with the Lipid-Lowering Effect of Statins in Hypercholesterolemic Patients 2014 ·Molecular Diagnosis & Therapy* ·Georgia Ragia, Vana Kolovou, Anna Tavridou, Laure Elens, Alexandros D. Tselepis, Moses Elisaf, Ron H. N. van Schaik, Genovefa Kolovou, Vangelis G. Manolopoulos	13
15	No impact of SLCO1B1 521T>C, 388A>G and 411G>A polymorphisms on response to statin therapy in the Greek population 2014 ·Molecular Biology Reports ·(unknown), Georgia Ragia, Vana Kolovou, Anna Tavridou, A. Tselepis, Moses Elisaf, Genovefa Kolovou, Vangelis G. Manolopoulos	24
16	Gene polymorphisms and thyroid function in patients with heart failure 2013 ·Endocrine ·Ioannis Vasiliadis, Genovefa Kolovou, Vana Kolovou, (unknown), Maria Boutsikou, Niki Katsiki, (unknown), Sophie Mavrogeni, (unknown), Costas Pantos, Dennis V. Cokkinos	10
17	A Randomized Trial of Genotype-Guided Dosing of Acenocoumarol and Phenprocoumon 2013 ·New England Journal of Medicine ·Talitha I. Verhoef, Georgia Ragia, Anthonius de Boer, Rita Barallon, Genovefa Kolovou, Vana Kolovou, Stavros Konstantinides, Saskia le Cessie, Efstratios Maltezos, F.J.M. van der Meer, Ken Redekop, (unknown), Frits R. Rosendaal, Rianne MF van Schie, Anna Tavridou, Dimitrios Tziakas, Mia Wadelius, Vangelis G. Manolopoulos, Anke H. Maitland‐van der Zee	162
18	Platelet activating factor levels and metabolism in tangier disease: a case study 2012 ·Lipids in Health and Disease ·Vana Kolovou, (unknown), George Stamatakis, (unknown), M.N. Xanthopoulou, Genovefa Kolovou, Constantinos A. Demopoulos	4
19	Ideal lipid profile and genes for an extended life span 2011 ·Current Opinion in Cardiology ·Genovefa Kolovou, Vana Kolovou, Ioannis Vasiliadis, Anthony S. Wierzbicki, Dimitri P. Mikhailidis	10
20	Cholesteryl Ester Transfer Protein Gene Polymorphisms and Longevity Syndrome 2010 ·The Open Cardiovascular Medicine Journal ·Genovefa Kolovou, (unknown), Katherine K. Anagnostopoulou, Peggy Kostakou, Vana Kolovou, Constantinos Mihas, Ioannis Vasiliadis, (unknown), Dimitri P. Mikhailidis, Dennis V. Cokkinos	18

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact